ecancer

Checkmate 067 - combined nivolumab and ipilimumab

Dr Suzanne Topalian - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA

12 Apr 2017

Durable responses to avelumab in patients with Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, New Brunswick, USA

12 Apr 2017

Understanding response and resistance to cancer therapy: Lessons learned from melanoma

Dr Jennifer Wargo - The University of Texas MD Anderson Cancer Center, Houston, USA

10 Apr 2017

Conference goals and cancer care in Brazil

Dr Carla Ismael - Presidente Sociedad Franco Brasilera de Oncología, Brasil

21 Dec 2016

Head and neck melanoma

Prof Carol Bradford - University of Michigan Medical School, Ann Arbor, USA

20 Dec 2016

Positive impact of specialised surgery in the fight against cancer

ESSO - SSO - BSSO

13 Dec 2016

Advances in malignant melanoma

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany

11 Nov 2016

Editor's ESMO 2016 roundup

Prof Gordon McVie - Editor in Chief, ecancer

24 Oct 2016

ESMO 2016 conference highlights

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

12 Oct 2016

Comment: Ipilimumab in high risk stage III melanoma

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Comment: Ribociclib for breast cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair

10 Oct 2016

More from ecancer